Aurobindo Pharma: Outcome of Board Meeting

The Board of Directors of the Company at its meeting held today February 7 2019 has inter alia transacted the following businesses:

1. Approved the Un-audited Financial Results of the Company
2. We enclose a copy of the Press Release.
3. Approved a 2nd Interim Dividend @125% i.e Rs.1.25 per equity share of Re.1/- each on the equity share capital of the Company.Fixed February 19 2019 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before February 28 2019.
4. Approved the reappointment of Mr. M.Sitarama Murty (DIN 01694236) as an Independent Director of the Company for the second term subject to the approval of the shareholders. Also approved the Postal Ballot notice for seeking approval of shareholders.
5. The Company has entered into a share subscription agreement to invest Rs. 15 crores in Synergy Remedies Private Limited.

The Board meeting commenced at 4.30 p.m and concluded at 7.30 p.m.